Read More 1 minute read Cannabis Markets Movers Psychedelic Stock Gainers And Losers From September 21, 2022 By Benzinga Insights Today, 10:39 AM GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 ALID
Read More 1 minute read Cannabis Markets Movers Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today By Benzinga Insights Today, 10:39 AM GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 ALID
Read More 1 minute read Cannabis Markets Movers Biomind Labs, Allied Among Top Psychedelic Movers Of Today By Benzinga Insights Today, 10:39 AM GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00 ALID
Read More 1 minute read Cannabis Markets Movers Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today By Benzinga Insights Today, 10:39 AM GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27 ALID
Read More 1 minute read Cannabis Markets Movers Psychedelic Stock Gainers And Losers From September 7, 2022 By Benzinga Insights Today, 10:39 AM GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 ATAI
Read More 1 minute read Cannabis Markets Movers Psychedelic Stock Gainers And Losers From September 6, 2022 By Benzinga Insights Today, 10:39 AM GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS: ATAI
Read More 1 minute read Cannabis Markets Movers Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today By Benzinga Insights Today, 10:39 AM GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29 ALID
Read More 1 minute read Cannabis Markets Movers Small Pharma, Cybin Among Top Psychedelic Movers Of Today By Benzinga Insights Today, 10:39 AM GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS: ALID
Read More 1 minute read Cannabis Markets Movers Psychedelic Stock Gainers And Losers From August 31, 2022 By Benzinga Insights Today, 10:39 AM GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24 ALID
Read More 2 minute read Biotech General Health Care Markets News Penny Stocks Psychedelics Success Stories Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression By Nicolas Jose Rodriguez Today, 10:39 AM Cybin Inc. CYBN